DBJCMS
CJ
TRKOMSPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
BridgeBiobridgebio.com EV DBJC |
BridgeBio is a biotechnology company developing first-in-class and best-in-class small molecule therapies for genetic conditions, | Palo Alto, California | 201-1000 | — |
Rocheroche.com EWMHAM |
— | — | — | |
Genentechgenentech.com |
— | — | — | |
Amgenamgen.com JM  FS LL |
Amgen is a biotechnology pioneer that uses living cells to make biologic medicines, with a research pipeline treating cancer, hear | Thousand Oaks, California | 5000+ | — |
Regeneronregeneron.com MJ  SB TC |
Regeneron is a biopharmaceutical company that invents, develops, and commercializes life-transforming medicines for people with se | Tarrytown, New York | 5000+ | — |
Biogenbiogen.com  CM PR KA |
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, that develops first-in-class medi | Cambridge, Massachusetts | 5000+ | — |
Novartisnovartis.com JHHLCQ |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
AbbVieabbvie.com  MC KKJF |
AbbVie is a global biopharmaceutical company that discovers and delivers innovative medicines and solutions for complex health iss | North Chicago, Illinois | 5000+ | — |
Vertexpharmaceuticalsvertexpharmaceuticals.com |
— | — | — | |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Alnylamalnylam.com EMHAHS |
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNAi therapeutics, developing medicines that silence | Cambridge, Massachusetts | 1001-5000 | — |
Modernamoderna.com  LJ MWTS |
— | — | — | |
Crispatherapeuticscrispatherapeutics.com |
— | — | — | |
Homologymedicinehomologymedicine.com |
— | — | — | |
OrphAI Therapeuticsai-therapeutics.com |
OrphAI Therapeutics (formerly AI Therapeutics) is a biotechnology company developing drugs for rare diseases and cancer, founded i | guilford center, Connecticut | 51-200 | — |
Akero Therapeuticsakerotx.com |
Akero Therapeutics is a clinical-stage biopharmaceutical company developing Efruxifermin (EFX), a novel therapy for metabolic dysf | South San Francisco, California | 51-200 | — |
Expansion Therapeuticsexpansionrx.com |
Expansion Therapeutics is a biotechnology company developing transformative oral medicines for severe RNA-mediated diseases, found | Jupiter, Florida | 11-50 | — |
HUYABIOhuyabio.com |
HUYABIO is a biopharmaceutical sourcing and development company that accelerates the global development of novel biopharmaceutical | San Diego, California | 51-200 | — |
Kardigankardigan.bio |
Kardigan is a patient-driven heart health company developing cardiovascular medicines that modify the underlying disease pathophys | Princeton, New Jersey | 51-200 | — |
InterMuneintermune.com |
InterMune is a biotechnology company focused on the research, development, and commercialization of innovative therapies for pulmo | South San Francisco, California | 51-200 | — |
Atalanta Therapeuticsatalantatx.com |
Atalanta Therapeutics is a Boston-based biotechnology company developing RNA interference therapies for intractable central nervou | Boston, Massachusetts | 11-50 | — |
REVOLUTION Medicinesrevolutionmedicines.com |
REVOLUTION Medicines is a biopharmaceutical company that discovers and develops new drugs targeting frontier oncology targets for | Redwood City, California | 201-1000 | — |
Kumquat Bioscienceskumquatbiosciences.com |
Kumquat Biosciences is a San Diego biotechnology company developing oncology medicines that target the KRAS pathway, including KRA | San Diego, California | 51-200 | — |
Boston Pharmaceuticalsbostonpharmaceuticals.com |
Boston Pharmaceuticals is a biopharmaceutical company that acquires and transforms innovative molecules into differentiated medici | Cambridge, Massachusetts | 51-200 | — |
Angitia Biopharmaceuticalsangitiabio.com |
Angitia is a clinical-stage biotechnology company discovering and developing therapeutics for serious musculoskeletal diseases, wi | Westlake Village, California | 51-200 | — |
Castle Creek Pharmacastlecreekpharma.com |
Castle Creek Pharma is a specialty pharmaceutical company developing and commercializing high-potential specialty drugs, including | Exton, Pennsylvania | 51-200 | — |
Agiosagios.com |
Agios is a commercial-stage biopharmaceutical company developing therapies for people with rare diseases, with a near-term focus o | Cambridge, Massachusetts | 201-1000 | — |
aTyr Pharmaatyrpharma.com |
aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company in San Diego, California, developing extracellular tRNA synthetase biology | San Diego, California | 51-200 | — |
Black Diamond Therapeuticsblackdiamondtherapeutics.com |
Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic m | Cambridge, Massachusetts | 11-50 | — |
Chemomab Therapeuticschemomab.com |
Chemomab Therapeutics is a biopharmaceutical company founded in 2011 and based in Tel Aviv, developing innovative treatments for p | Tel Aviv, Tel Aviv District | 51-200 | — |
| Run live for more | ||||
BridgeBio is a biotechnology company developing first-in-class and best-in-class small molecule therapies for genetic conditions, with a late-stage pipeline including acoaramidis for variant transthyretin amyloidosis (ATTRv), infigratinib for achondroplasia and hypochondroplasia, and encaleret for autosomal dominant hypocalcemia type 1 and chronic hypoparathyroidism.
Companies like BridgeBio include Roche, Genentech, Amgen, Regeneron, Biogen. See the full list of 24 competitors and alternatives above.
BridgeBio has approximately 201-1000 employees and is in the Biotechnology Research industry.
BridgeBio is headquartered in Palo Alto, California.
BridgeBio operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at BridgeBio are listed above, including leaders across executive, finance, sales and operations.